YKL-40 as a novel biomarker related to white matter damage and cognitive impairment in patients with cerebral small vessel disease
- 8 March 2023
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1807, 148318
Abstract
No abstract availableKeywords
Funding Information
- Anhui Medical University (2020xkjT026)
- Natural Science Foundation of Anhui Province (1908085QH322)
- Anhui Provincial Key Research and Development Plan (202104j07020031)
- National Natural Science Foundation of China (81771154)
This publication has 66 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Microstructural integrity of the cingulum is related to verbal memory performance in elderly with cerebral small vessel diseaseNeuroImage, 2013
- The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failureImmunobiology, 2012
- Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertensionBMC Cardiovascular Disorders, 2012
- Montreal Cognitive Assessment in Detecting Cognitive Impairment in Chinese Elderly Individuals: A Population-Based StudyJournal of Geriatric Psychiatry and Neurology, 2011
- Correlations between MRI white matter lesion location and executive function and episodic memoryNeurology, 2011
- Hypertension and Cerebral Diffusion Tensor Imaging in Small Vessel DiseaseStroke, 2010
- The cell wall polysaccharide metabolism of the brown alga Ectocarpus siliculosus. Insights into the evolution of extracellular matrix polysaccharides in EukaryotesNew Phytologist, 2010
- Classification of White Matter Lesions on Magnetic Resonance Imaging in Elderly PersonsBiological Psychiatry, 2008
- Subcortical Ischemic Vascular DementiaNeurologic Clinics, 2007